FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

John Macdonald

Research Profile

Procedures

Chemicals & Drugs

Disorders

Concepts & Ideas

Co-author Network

Publications

TOP 3
William F Regine; Kathryn A Winter; Ross Abrams; Howard Safran; John P Hoffman; Andre Konski; Al B Benson; John S Macdonald; tyvin rich; Christopher G Willett
Fluorouracil-based chemoradiation with either gemcitabine or fluorouracil chemotherapy after resection of pancreatic adenocarcinoma: 5-year analysis of the U.S. Intergroup/RTOG 9704 phase III trial.
William F Regine; Kathryn A Winter; Ross A Abrams; Howard Safran; John P Hoffman; Andre Konski; Al B Benson; John S Macdonald; Mahesh R Kudrimoti; Mitchel L Fromm; Michael G Haddock; Paul Schaefer; Christopher G Willett; tyvin rich
Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: a randomized controlled trial.
Peter C Enzinger; Jacqueline K Benedetti; Jeffrey A Meyerhardt; Sheryl McCoy; Scott A Hundahl; John S Macdonald; Charlie S Fuchs
Impact of hospital volume on recurrence and survival after surgery for gastric cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of John Macdonald (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: William F Regine; Kathryn A Winter; Ross Abrams; Howard Safran; John P Hoffman; Andre Konski; Al B Benson; John S Macdonald; tyvin rich; Christopher G Willett
Fluorouracil-based chemoradiation with either gemcitabine or fluorouracil chemotherapy after resection of pancreatic adenocarcinoma: 5-year analysis of the U.S. Intergroup/RTOG 9704 phase III trial.
Annals of surgical oncology 2011;18(5):1319-26.
2008: William F Regine; Kathryn A Winter; Ross A Abrams; Howard Safran; John P Hoffman; Andre Konski; Al B Benson; John S Macdonald; Mahesh R Kudrimoti; Mitchel L Fromm; Michael G Haddock; Paul Schaefer; Christopher G Willett; tyvin rich
Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: a randomized controlled trial.
JAMA : the journal of the American Medical Association 2008;299(9):1019-26.
2007: Peter C Enzinger; Jacqueline K Benedetti; Jeffrey A Meyerhardt; Sheryl McCoy; Scott A Hundahl; John S Macdonald; Charlie S Fuchs
Impact of hospital volume on recurrence and survival after surgery for gastric cancer.
Annals of surgery 2007;245(3):426-34.
2007: Harold O Douglass; Scott A Hundahl; John S Macdonald; Vijay P Khatri
Gastric cancer: D2 dissection or low Maruyama Index-based surgery--a debate.
Surgical oncology clinics of North America 2007;16(1):133-55.
2006: Steven R Smalley; Jacqueline K Benedetti; Stephen K Williamson; John M Robertson; Norman C. Estes; Tracy Maher; Bernard Fisher; tyvin rich; James A Martenson; John W Kugler; Al B Benson; Daniel G Haller; Robert J Mayer; James N Atkins; Christine Cripps; John Pedersen; Phillip O Periman; Michael S Tanaka; Cynthia G Leichman; John S Macdonald
Phase III trial of fluorouracil-based chemotherapy regimens plus radiotherapy in postoperative adjuvant rectal cancer: GI INT 0144.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(22):3542-7.
2006: Robert P Whitehead; Sheryl McCoy; John S Macdonald; Saul E Rivkin; Marcus A Neubauer; Shaker R Dakhil; Heinz-Josef Lenz; Michael S Tanaka; James L Abbruzzese
Phase II trial of R115777 (NSC #70818) in patients with advanced colorectal cancer: a Southwest Oncology Group study.
Investigational new drugs 2006;24(4):335-41.
2006: Joseph M Unger; Charles A Coltman; John J Crowley; Laura F Hutchins; Silvana Martino; Robert B Livingston; John S Macdonald; Charles D Blanke; David R Gandara; E David Crawford; Kathy S Albain
Impact of the year 2000 Medicare policy change on older patient enrollment to cancer clinical trials.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(1):141-4.
2005: John S Macdonald; Sheryl McCoy; Robert P Whitehead; Syma Iqbal; James L Wade Iii; Jeffrey K Giguere; James L Abbruzzese
A phase II study of farnesyl transferase inhibitor R115777 in pancreatic cancer: a Southwest oncology group (SWOG 9924) study.
Investigational new drugs 2005;23(5):485-7.
2005: Cynthia G Leichman; Jacqueline K Benedetti; Mark M Zalupski; Howard Hochster; Anthony F Shields; Heinz-Josef Lenz; James L Wade Iii; James D Bearden Iii; John S Macdonald
Assessment of infusional 5-fluorouracil schedule and dose intensity: a Southwest Oncology Group and Eastern Cooperative Oncology Group study.
Clinical colorectal cancer 2005;5(2):119-23.
2005: Elizabeth A Poplin; Jacqueline K Benedetti; Norman C. Estes; Daniel G Haller; Robert J Mayer; Richard M Goldberg; Geoffrey R Weiss; Saul E Rivkin; John S Macdonald
Phase III Southwest Oncology Group 9415/Intergroup 0153 randomized trial of fluorouracil, leucovorin, and levamisole versus fluorouracil continuous infusion and levamisole for adjuvant treatment of stage III and high-risk stage II colon cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(9):1819-25.
2005: Kari Chansky; Jacqueline K Benedetti; John S Macdonald
Differences in toxicity between men and women treated with 5-fluorouracil therapy for colorectal carcinoma.
Cancer 2005;103(6):1165-71.
2004: Robert P Whitehead; Jacqueline K Benedetti; James L Abbruzzese; Bach Ardalan; Stephen Williamson; Ellen R Gaynor; Stanley P Balcerzak; John S Macdonald
A phase II pilot study of high-dose 24-hour continuous infusion of 5-FU and leucovorin and low-dose PALA for patients with colorectal cancer: a Southwest Oncology Group study.
Investigational new drugs 2004;22(4):467-73.
2004: John S Macdonald
Clinical overview: adjuvant therapy of gastrointestinal cancer.
Cancer chemotherapy and pharmacology 2004;54 Suppl 1():S4-11.
2004: Robert P Whitehead; Jacqueline K Benedetti; James L Abbruzzese; Bach Ardalan; J Wendall Goodwin; Stanley P Balcerzak; Wolfram E Samlowski; Heinz-Josef Lenz; John S Macdonald
A phase II study of high-dose 24 hour continuous infusion 5-FU and leucovorin and low-dose PALA for patients with advanced pancreatic adenocarcinoma: a Southwest Oncology Group Study.
Investigational new drugs 2004;22(3):335-41.
2004: Leonard L Gunderson; Daniel J Sargent; Joel E Tepper; Norman Wolmark; Michael J O'Connell; Mirsada Begovic; Cristine Allmer; Linda H Colangelo; Steven R Smalley; Daniel G Haller; James A Martenson; Robert J Mayer; tyvin rich; Jaffer A Ajani; John S Macdonald; Christopher G Willett; Richard M Goldberg
Impact of T and N stage and treatment on survival and relapse in adjuvant rectal cancer: a pooled analysis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(10):1785-96.
2004: Jeffrey A Meyerhardt; Joel E Tepper; Donna Niedzwiecki; Donna Hollis; A David McCollum; Denise Brady; Michael J O'Connell; Robert J Mayer; Bernard Cummings; Christopher Willett; John S Macdonald; Al B Benson; Charlie S Fuchs
Impact of body mass index on outcomes and treatment-related toxicity in patients with stage II and III rectal cancer: findings from Intergroup Trial 0114.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(4):648-57.
2004: Susan G Urba; Kari Chansky; Peter J Vanveldhuizen; Robert E Pluenneke; Jacqueline K Benedetti; John S Macdonald; James L Abbruzzese
Gemcitabine and cisplatin for patients with metastatic or recurrent esophageal carcinoma: a Southwest Oncology Group Study.
Investigational new drugs 2004;22(1):91-7.
2004: Jeffrey A Meyerhardt; Joel E Tepper; Donna Niedzwiecki; Donna Hollis; Deborah Schrag; John Z Ayanian; Michael J O'Connell; Jane C Weeks; Robert J Mayer; Christopher G Willett; John S Macdonald; Al B Benson; Charlie S Fuchs
Impact of hospital procedure volume on surgical operation and long-term outcomes in high-risk curatively resected rectal cancer: findings from the Intergroup 0114 Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(1):166-74.
2003: John S Macdonald
Chemotherapy in the management of gastric cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(23 Suppl):276s-279s.
2003: Joseph M Unger; Michael LeBlanc; John J Crowley; H Barton Grossman; Ronald B Natale; Antoinette J Wozniak; James R Berenson; Alan F List; William A Peters; Robert C Flanigan; John S Macdonald; Muhyi Al-Sarraf; Ian M Thompson; Charles A Coltman
Estimating the impact of new clinical trial proven cancer therapy and cancer chemoprevention on population mortality: the Karnofsky Memorial lecture.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(23 Suppl):246s-252s.
2003: Jeffrey A Meyerhardt; Paul J Catalano; Deborah Schrag; John Z Ayanian; Daniel G Haller; Robert J Mayer; John S Macdonald; Al B Benson; Charlie S Fuchs
Association of hospital procedure volume and outcomes in patients with colon cancer at high risk for recurrence.
Annals of internal medicine 2003;139(8):649-57.
2003: Jeffrey A Meyerhardt; Paul J Catalano; Daniel G Haller; Robert J Mayer; Al B Benson; John S Macdonald; Charlie S Fuchs
Influence of body mass index on outcomes and treatment-related toxicity in patients with colon carcinoma.
Cancer 2003;98(3):484-95.
2003: Jeffrey A Meyerhardt; Paul J Catalano; Daniel G Haller; Robert J Mayer; John S Macdonald; Al B Benson; Charlie S Fuchs
Impact of diabetes mellitus on outcomes in patients with colon cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(3):433-40.
2002: Cynthia G Leichman; Kari Chansky; John S Macdonald; Michael A Doukas; G Thomas Budd; Jeffrey K Giguere; James L Abbruzzese
Biochemical modulation of 5-fluorouacil through dihydropyrimidine dehydrogenase inhibition: a Southwest Oncology Group phase II trial of eniluracil and 5-fluorouracil in advanced resistant colorectal cancer.
Investigational new drugs 2002;20(4):419-24.
2002: Mace L Rothenberg; Jacqueline K Benedetti; John S Macdonald; Thomas E Seay; M A Neubauer; C S George; M S Tanaka; Jeffrey K Giguere; B T Pruitt; James L Abbruzzese
Phase II trial of 5-fluorouracil plus eniluracil in patients with advanced pancreatic cancer: a Southwest Oncology Group study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(10):1576-82.
2002: Robert C Miller; Daniel J Sargent; James A Martenson; John S Macdonald; Daniel Haller; Robert J Mayer; Leonard L Gunderson; tyvin rich; Stephen S Cha; Michael J O'Connell
Acute diarrhea during adjuvant therapy for rectal cancer: a detailed analysis from a randomized intergroup trial.
International journal of radiation oncology, biology, physics 2002;54(2):409-13.
2002: Leonard L Gunderson; Daniel J Sargent; Joel E Tepper; Michael J O'Connell; Cristine Allmer; Steven R Smalley; James A Martenson; Daniel G Haller; Robert J Mayer; tyvin rich; Jaffer A Ajani; John S Macdonald; Richard M Goldberg
Impact of T and N substage on survival and disease relapse in adjuvant rectal cancer: a pooled analysis.
International journal of radiation oncology, biology, physics 2002;54(2):386-96.
2002: A David McCollum; Paul J Catalano; Daniel G Haller; Robert J Mayer; John S Macdonald; Al B Benson; Charlie S Fuchs
Outcomes and toxicity in african-american and caucasian patients in a randomized adjuvant chemotherapy trial for colon cancer.
Journal of the National Cancer Institute 2002;94(15):1160-7.
2002: Scott A Hundahl; John S Macdonald; Jacqueline K Benedetti; Thomas Fitzsimmons
Surgical treatment variation in a prospective, randomized trial of chemoradiotherapy in gastric cancer: the effect of undertreatment.
Annals of surgical oncology 2002;9(3):278-86.
2002: Joel E Tepper; M O'Connell; Donna Niedzwiecki; Donna Hollis; Al B Benson; Bernard Cummings; Leonard L Gunderson; John S Macdonald; James A Martenson; Robert J Mayer
Adjuvant therapy in rectal cancer: analysis of stage, sex, and local control--final report of intergroup 0114.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(7):1744-50.
2001: John S Macdonald; Steven R Smalley; Jacqueline K Benedetti; Scott A Hundahl; Norman C. Estes; Grant N Stemmermann; Daniel G Haller; Jaffer A Ajani; Leonard L Gunderson; J M Jessup; James A Martenson
Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction.
The New England journal of medicine 2001;345(10):725-30.
2001: John S Macdonald; A B Astrow
Adjuvant therapy of colon cancer.
Seminars in oncology 2001;28(1):30-40.
2001: Joel E Tepper; Michael J O'Connell; Donna Niedzwiecki; Donna Hollis; Carolyn Corlies Compton; Al B Benson; Bernard Cummings; Leonard L Gunderson; John S Macdonald; Robert J Mayer
Impact of number of nodes retrieved on outcome in patients with rectal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(1):157-63.
2000: John S Macdonald; J L Jacobson; M Modiano; D F Moore; David R Gandara; L E Schroder; Robert A Chapman
A phase II trial of etoposide, leucovorin, 5-FU, and interferon alpha 2b (ELFI) + G-CSF for patients with pancreatic adenocarcinoma: a Southwest Oncology Group study (SWOG 9413).
Investigational new drugs 2000;18(3):269-73.
2000: John S Macdonald; J L Jacobson; S J Ketchel; G Weiss; Sarah A Taylor; G Mills; J P Kuebler; S Rivkin; M Conrad
A phase II trial of topotecan in esophageal carcinoma: a Southwest Oncology Group study (SWOG 9339).
Investigational new drugs 2000;18(2):199-202.
1999: Cynthia G Leichman; J R Jacobson; M Modiano; J R Daniels; Mark M Zalupski; James Doroshow; W S Fletcher; John S Macdonald
Hepatic chemoembolization combined with systemic infusion of 5-fluorouracil and bolus leucovorin for patients with metastatic colorectal carcinoma: A Southwest Oncology Group pilot trial.
Cancer 1999;86(5):775-81.
1999: Jay S Cooper; M D Guo; Arnold Herskovic; John S Macdonald; J A Martenson; Muhyi Al-Sarraf; Roger W. Byhardt; Anthony H Russell; J J Beitler; S Spencer; Sucha O Asbell; Mary V Graham; L L Leichman
Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group.
JAMA : the journal of the American Medical Association 1999;281(17):1623-7.
1998: Norman C. Estes; John S Macdonald; K Touijer; Jacqueline K Benedetti; J Jacobson
Inadequate documentation and resection for gastric cancer in the United States: a preliminary report.
The American surgeon 1998;64(7):680-5.
1997: John S Macdonald
Adjuvant therapy for colon cancer.
CA: a cancer journal for clinicians 1997;47(4):243-56.
1997: Robert P Whitehead; J Jacobson; T D Brown; Sarah A Taylor; Geoffrey R Weiss; John S Macdonald
Phase II trial of paclitaxel and granulocyte colony-stimulating factor in patients with pancreatic carcinoma: a Southwest Oncology Group study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(6):2414-9.
1997: Joel E Tepper; Michael J O'Connell; G R Petroni; Donna Hollis; E Cooke; Al B Benson; Bernard Cummings; Leonard L Gunderson; John S Macdonald; James A Martenson
Adjuvant postoperative fluorouracil-modulated chemotherapy combined with pelvic radiation therapy for rectal cancer: initial results of intergroup 0114.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(5):2030-9.
1997: John S Macdonald; Jacqueline K Benedetti; M Modiano; D S Alberts
Phase II evaluation of topotecan in patients with advanced colorectal cancer. A Southwest Oncology Group trial (SWOG 9241).
Investigational new drugs 1997;15(4):357-9.
1997: Jacqueline K Benedetti; H A Burris; Stanley P Balcerzak; John S Macdonald
Phase II trial of topotecan in advanced gastric cancer: a Southwest Oncology Group study.
Investigational new drugs 1997;15(3):261-4.
1997: J G Wall; Jacqueline K Benedetti; M A O'Rourke; R B Natale; John S Macdonald
Phase II trial to topotecan in hepatocellular carcinoma: a Southwest Oncology Group study.
Investigational new drugs 1997;15(3):257-60.
1997: John S Macdonald
Therapies for advanced colorectal cancer: the role of interferon and leucovorin.
Tumori 1997;83(1 Suppl):S67-9.
1997: John S Macdonald; D Haller
Update on adjuvant therapy of colon cancer.
Tumori 1997;83(1 Suppl):S39-41.
1996: S F Schnall; John S Macdonald
Chemotherapy of adenocarcinoma of the pancreas.
Seminars in oncology 1996;23(2):220-8.
1996: John S Macdonald
Pancreatic cancer.
Seminars in oncology 1996;23(2):199.
1995: Thomas R Klumpp; Kenneth F Mangan; SL Goldberg; E S Pearlman; John S Macdonald
Granulocyte colony-stimulating factor accelerates neutrophil engraftment following peripheral-blood stem-cell transplantation: a prospective, randomized trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(6):1323-7.
1995: SL Goldberg; Kenneth F Mangan; Thomas R Klumpp; John S Macdonald; C Thomas; M T Mullaney; F C Au
Complications of peripheral blood stem cell harvesting: review of 554 PBSC leukaphereses.
Journal of hematotherapy 1995;4(2):85-90.
1995: John S Macdonald; S F Schnall
Adjuvant treatment of gastric cancer.
World journal of surgery 1995;19(2):221-5.
1994: Thomas R Klumpp; J H Herman; Kenneth F Mangan; M K Schnell; SL Goldberg; John S Macdonald
Lack of transmission of neutrophil and platelet antibodies by intravenous immunoglobulin in bone marrow transplant patients.
Transfusion 1994;34(8):677-9.
1994: SL Goldberg; Kenneth F Mangan; Thomas R Klumpp; T M Cropper; S F Schnall; John S Macdonald
Lack of a graft-versus-leukemia effect in an immunologically privileged sanctuary site.
Bone marrow transplantation 1994;14(1):180-1.
1994: John S Macdonald
Endocrine tumors: molecular biology at the bedside?
Current opinion in oncology 1994;6(1):51-2.
1994: Kenneth F Mangan; M T Mullaney; Thomas R Klumpp; SL Goldberg; John S Macdonald
A retrospective comparison of three different methods for mobilization of peripheral blood stem cells.
Progress in clinical and biological research 1994;389():441-8.
1993: Thomas R Klumpp; Kenneth F Mangan; L D Glenn; D R Malaspina; T Cropper; M Mullaney; John S Macdonald
Phase I/II study of high-dose cyclophosphamide, etoposide and cisplatin followed by autologous bone marrow or peripheral blood stem cell transplantation in patients with poor prognosis Hodgkin's disease or non-Hodgkin's lymphoma.
Bone marrow transplantation 1993;12(4):337-45.
1993: S Schnall; John S Macdonald
Mitomycin therapy in gastric cancer.
Oncology 1993;50 Suppl 1():70-7.
1993: Thomas R Klumpp; Kenneth F Mangan; L D Glenn; John S Macdonald
Phase II pilot study of high-dose busulfan and CY followed by autologous BM or peripheral blood stem cell transplantation in patients with advanced chemosensitive breast cancer.
Bone marrow transplantation 1993;11(4):337-9.
1993: Thomas R Klumpp; J H Herman; Kenneth F Mangan; John S Macdonald
Graft failure following neutrophil-specific alloantigen mismatched allogeneic BMT.
Bone marrow transplantation 1993;11(3):243-5.
1992: John S Macdonald; K A Havlin
Etoposide in gastric cancer.
Seminars in oncology 1992;19(6 Suppl 13):59-62.
1992: Thomas R Klumpp; J H Herman; John S Macdonald; M K Schnell; M Mullaney; Kenneth F Mangan
Autoimmune neutropenia following peripheral blood stem cell transplantation.
American journal of hematology 1992;41(3):215-7.
1991: S F Schnall; John S Macdonald
Adjuvant therapy in colorectal carcinoma.
Seminars in oncology 1991;18(6):560-70.
1991: John S Macdonald
Parathyroid neoplasia.
Current opinion in oncology 1991;3(1):139-41.